bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
Echelon Biosciences ionisable lipids
Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...
BioStatus CyTRAK Orange fluorescent dye
BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...
Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent
Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies...
